Application of latent HIV-1 infected cellular models to therapeutic intervention

S. T. Butera, T. M. Folks

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

The 10-year period of clinical latency following infection with the human immunodeficiency virus type-1 remains as a tremendous opportunity for therapeutic intervention. To decipher the viral and cellular mechanisms involved in controlling active and nonproductive viral expression, chronically infected cell lines have been developed which mimic in vivo latency at a cellular level. This review compares these models of chronic infection, emphasizing the advantages and limitations of this approach to the understanding of AIDS progression. In addition, it accentuates the utility of these models of chronic infection in the development and testing of novel drugs aimed at altering the efferent component of the HIV-1 life cycle. It is this component of the viral life cycle that has remained largely unexplored and open to novel therapeutic strategies for the prevention of lethal immunosuppression.

Original languageEnglish (US)
Pages (from-to)991-995
Number of pages5
JournalAIDS Research and Human Retroviruses
Volume8
Issue number6
StatePublished - 1992
Externally publishedYes

Fingerprint

HIV-1
Life Cycle Stages
Infection
Viral Structures
Immunosuppression
Acquired Immunodeficiency Syndrome
Therapeutics
Cell Line
Pharmaceutical Preparations

ASJC Scopus subject areas

  • Immunology
  • Virology

Cite this

Application of latent HIV-1 infected cellular models to therapeutic intervention. / Butera, S. T.; Folks, T. M.

In: AIDS Research and Human Retroviruses, Vol. 8, No. 6, 1992, p. 991-995.

Research output: Contribution to journalArticle

@article{b8c68b8c72d8414b96a6bfb27cd8f9b6,
title = "Application of latent HIV-1 infected cellular models to therapeutic intervention",
abstract = "The 10-year period of clinical latency following infection with the human immunodeficiency virus type-1 remains as a tremendous opportunity for therapeutic intervention. To decipher the viral and cellular mechanisms involved in controlling active and nonproductive viral expression, chronically infected cell lines have been developed which mimic in vivo latency at a cellular level. This review compares these models of chronic infection, emphasizing the advantages and limitations of this approach to the understanding of AIDS progression. In addition, it accentuates the utility of these models of chronic infection in the development and testing of novel drugs aimed at altering the efferent component of the HIV-1 life cycle. It is this component of the viral life cycle that has remained largely unexplored and open to novel therapeutic strategies for the prevention of lethal immunosuppression.",
author = "Butera, {S. T.} and Folks, {T. M.}",
year = "1992",
language = "English (US)",
volume = "8",
pages = "991--995",
journal = "AIDS Research and Human Retroviruses",
issn = "0889-2229",
publisher = "Mary Ann Liebert Inc.",
number = "6",

}

TY - JOUR

T1 - Application of latent HIV-1 infected cellular models to therapeutic intervention

AU - Butera, S. T.

AU - Folks, T. M.

PY - 1992

Y1 - 1992

N2 - The 10-year period of clinical latency following infection with the human immunodeficiency virus type-1 remains as a tremendous opportunity for therapeutic intervention. To decipher the viral and cellular mechanisms involved in controlling active and nonproductive viral expression, chronically infected cell lines have been developed which mimic in vivo latency at a cellular level. This review compares these models of chronic infection, emphasizing the advantages and limitations of this approach to the understanding of AIDS progression. In addition, it accentuates the utility of these models of chronic infection in the development and testing of novel drugs aimed at altering the efferent component of the HIV-1 life cycle. It is this component of the viral life cycle that has remained largely unexplored and open to novel therapeutic strategies for the prevention of lethal immunosuppression.

AB - The 10-year period of clinical latency following infection with the human immunodeficiency virus type-1 remains as a tremendous opportunity for therapeutic intervention. To decipher the viral and cellular mechanisms involved in controlling active and nonproductive viral expression, chronically infected cell lines have been developed which mimic in vivo latency at a cellular level. This review compares these models of chronic infection, emphasizing the advantages and limitations of this approach to the understanding of AIDS progression. In addition, it accentuates the utility of these models of chronic infection in the development and testing of novel drugs aimed at altering the efferent component of the HIV-1 life cycle. It is this component of the viral life cycle that has remained largely unexplored and open to novel therapeutic strategies for the prevention of lethal immunosuppression.

UR - http://www.scopus.com/inward/record.url?scp=0026668174&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026668174&partnerID=8YFLogxK

M3 - Article

C2 - 1503831

AN - SCOPUS:0026668174

VL - 8

SP - 991

EP - 995

JO - AIDS Research and Human Retroviruses

JF - AIDS Research and Human Retroviruses

SN - 0889-2229

IS - 6

ER -